We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.AuthorsPrice CF; Tyssen D; Sonza S; Davie A; Evans S; Lewis GR; Xia S; Spelman T; Hodsman P; Moench TR; Humberstone A; Paull JR; Tachedjian GPublicationPloS one, 2011, Vol 6, Issue 9, pe24095ISSN1932-6203Publication typearticleDOI10.1371/journal.pone.0024095